Crossing the line: part 2.
Blaivas
Jerry G
JG
D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D004345:Drug Industry / Q000941:ethics*; D006801:Humans; D007783:Lactones / Q000009:adverse effects*; D013450:Sulfones / Q000009:adverse effects*
D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib